Totus Medicines to Present First-in-Class Covalent IRF5 Inhibitor Data at AAI IMMUNOLOGY2026

First-in-class, covalent, oral small molecule inhibitor targeting IRF5IRF5 is a genetically validated driver of autoimmune diseases, including ...
News Medical

Accelerating small molecule discovery for RNA drug targets

This article and associated images are based on a poster originally authored by Adam Buckle, Julia Unsicker and Iain McWilliam and presented at ELRIG Drug Discovery 2025 in affiliation with Arrayjet ...
ksn.com

Proteros biostructures and Orion Pharma agree on a long-term multi-target collaboration including the assembly of a joint novel and unique HTS small-molecule screening library ...

Multi-target research partnership for drug discovery in oncology and pain Assembly of novel high-diversity small molecule library Library collection distinguished by novel unique design concepts based ...
Seeking Alpha

N2OFF: MitoCareX Bio Announces Positive In Vitro Results from Its Mitochondrial Carrier Small Molecule Platform

MITOLINE ™ Algorithm Powers Development of First-in-Class Small Molecules Targeting a Mitochondrial Carrier for Inflammatory Metabolic Diseases – A Market Projected to Exceed $120 billion by 2030 ...